1-5 of 5
Julio Chavez, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hepatitis B Infection Is Associated with an Increased Risk of Non-Hodgkin Lymphoma: A Meta-Analysis.

Samir Dalia, MD, Julio Chavez, MD, Jorge J Castillo, MD, Lubomir Sokol, MD, Ph.D
Journal: Blood
Blood (2012) 120 (21): 2658.
https://doi.org/10.1182/blood.V120.21.2658.2658
Published: 2012
Journal Articles

Gene Deletions of 17p or 11q Are Independent Predictors of Decreased Progression-Free Survival and Overall Survival Following Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia

Julio Chavez, MD, Jongphil Kim, PhD, Samir Dalia, MD, Mohamed A. Kharfan-Dabaja, MD, Javier Pinilla-Ibarz, MD, PhD, Claudio Anasetti, MD, Frederick L Locke, MD
Journal: Blood
Blood (2012) 120 (21): 2007.
https://doi.org/10.1182/blood.V120.21.2007.2007
Published: 2012
Journal Articles

BCL-2 Expression at the Time of Diagnosis Affects the Clinical Outcome of Patients with Germinal Center and Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Chemo-Immunotherpy

Sulada Pukiat, MD, Nuttapong Ngamphaiboon, MD, Pooja Advani, MBBS, Julio Chavez, MD, George Deeb, MD, Anjana Elefante, Pharm, D, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2010) 116 (21): 3130.
https://doi.org/10.1182/blood.V116.21.3130.3130
Published: 2010
Journal Articles

The Expression of Bcl-6 In Diffuse Large B Cell Lymphoma (DLBCL) Is Associated with Improved Progression Free Survival and Overall Survival Following Front-Line Rituximab-Chemotherapy

Pooja Advani, MBBS, Nuttapong Ngamphaiboon, MD, Sulada Pukiat, MD, Julio Chavez, MD, George Deeb, MD, Anjana Elefante, Pharm, D, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2010) 116 (21): 5073.
https://doi.org/10.1182/blood.V116.21.5073.5073
Published: 2010
Journal Articles

Classification of Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) According to the Han's Criteria Defines Two Groups of Patients with Different Clinical Outcomes Following Systemic Rituximab-Multi Agent Anthracycline-Based Therapy.

Julio Chavez, MD, Mark Walsh, Pharm, D, Francisco J Hernandez-Ilizaliturri, MD, Anjana Elefante, Pharm, D, Myron S. Czuczman, MD
Journal: Blood
Blood (2009) 114 (22): 623.
https://doi.org/10.1182/blood.V114.22.623.623
Published: 2009